Search results
Weight loss drugs are so hot that Eli Lilly is expecting $2 billion more in sales this year
Quartz· 5 days agoEli Lilly stock jumped 5% during Tuesday morning trading to about $773 a share after the pharma giant reported better-than-expected sales of its weight ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 4 days ago, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Midland Reporter-Telegram· 5 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune· 2 days agoIndianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss ...
Brokerages Set Eli Lilly and Company (NYSE:LLY) Target Price at $728.05
ETF DAILY NEWS· 6 days agoShares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nineteen ratings firms that ...
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance via AOL· 5 days agoJust a few short years after coming to market, the latest GLP-1 drugs are showing versatility in...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
San Francisco Chronicle· 5 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
Eli Lilly Stock Surges as Weight Loss Drugs Continue to Fuel Growth
Investopedia· 5 days agoEli Lilly (LLY) stock gained 6% Tuesday after the drugmaker reported first-quarter earnings that...
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 days agoImage source: The Motley Fool. Eli Lilly (NYSE: LLY) Q1 2024 Earnings Call Apr 30, 2024, 10:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Unveiling Eli Lilly and Co (LLY)'s Value: Is It Really Priced Ri
Guru Focus· 2 days agoEli Lilly and Co (LLY, Financial) has recently experienced a daily loss of 2.47%, although it has gained 10.52% over the past three months. This analysis ...